CellCept 250 mg/1

CellCept 250 mg capsules contain mycophenolate mofetil, an immunosuppressant used to prevent organ rejection. This medication is commonly prescribed for transplant patients.

CellCept 250 mg capsules are primarily used to prevent rejection in organ transplant patients. Mycophenolate mofetil works by suppressing the immune system, helping the body accept the transplanted organ. This medication is often used in combination with other immunosuppressants. Patients should consult their healthcare provider to understand the specific uses of CellCept in their treatment plan.

Common effects of CellCept 250 mg capsules may include nausea, vomiting, diarrhea, and abdominal pain. Some patients may experience fatigue or infections due to the immunosuppressant nature of the medication. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

CellCept 250 mg capsules should be handled with care, as the medication can be harmful if crushed or inhaled. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider, as mycophenolate mofetil can cause birth defects. Regular blood tests may be required to monitor for potential side effects.

CellCept 250 mg capsules may interact with other medications, including antacids containing magnesium or aluminum, which can reduce the absorption of mycophenolate mofetil. Patients should avoid taking CellCept with cholestyramine, as it can decrease the effectiveness of the medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.